Innovative pharmaceutical patent portfolio from Osteologix is on sale from Metis Partners

Innovative pharmaceutical patent portfolio from Osteologix is on sale from Metis Partners

  An exciting pharmaceutical patent portfolio from the Osteologix group is on sale from Metis Partners, the award-winning commercial intellectual property consulting firm. In recent years, bone diseases such as osteoporosis have been increasing due to longer life expectancy and related vitamin and mineral deficiencies. The NHS states that osteoporosis is now a ‘fairly common […]

read more